Literature DB >> 17223126

Tracking antigen-specific CD8+ T cells in the rat using MHC class I multimers.

Valérie Duplan1, Elsa Suberbielle, Catherine E Napper, Etienne Joly, Abdelhadi Saoudi, Daniel Gonzalez-Dunia.   

Abstract

Studies of the quantitative and qualitative aspects of anti-microbial, anti-tumoral or autoreactive immune responses have been greatly facilitated by the possibility to stain antigen-specific CD8(+) T cells using fluorescently labeled multimeric major histocompatibility complex (MHC) class I/peptide complexes. So far, this technology has been developed for human and mouse, but not yet in the rat. Here, we describe the generation of the first rat MHC multimer. We produced a rat RT1(l) Pro5 MHC Pentamer combined with the immunodominant peptide for Borna disease virus (BDV), in order to study the characteristics of the antiviral CD8(+) T cell response. BDV is an RNA virus that can cause persistent infections of the central nervous system (CNS), often associated with prominent brain inflammation. In adult Lewis rats, of the RT1(l) MHC haplotype, BDV infection leads to severe immune-mediated neurological symptoms. The pathogenic role of the immune response is due primarily to antiviral CD8(+) T cells, many of them being specific for an immunodominant epitope located in the BDV nucleoprotein (N(230-238)). Ex vivo flow cytometry analyses revealed that 3 to 12% of CD8(+) T cells found in the brains of BDV-infected rats stained positively with the BDV-Pentamer. Interestingly, the frequency of Pentamer-positive cells increased up to 3.3 fold after a short resting period in culture. Virus-specific CD8(+) T cells were mainly detected in the brain and were virtually undetectable in peripheral lymphoid organs. This novel rat Pro5 MHC Pentamer represents an attractive tool for the detection, isolation and characterization of antigen-specific CD8(+) T cell responses in the rat.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17223126     DOI: 10.1016/j.jim.2006.11.008

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  Adoptive Immunotherapy after Allogeneic Hematopoietic Progenitor Cell Transplantation: New Perspectives for Transfusion Medicine.

Authors:  Susanne Hofmann; Jochen Greiner
Journal:  Transfus Med Hemother       Date:  2011-05-11       Impact factor: 3.747

2.  Retrogenic modeling of experimental allergic encephalomyelitis associates T cell frequency but not TCR functional affinity with pathogenicity.

Authors:  Rajshekhar Alli; Phuong Nguyen; Terrence L Geiger
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

3.  Neurons are MHC class I-dependent targets for CD8 T cells upon neurotropic viral infection.

Authors:  Grégoire Chevalier; Elsa Suberbielle; Céline Monnet; Valérie Duplan; Guillaume Martin-Blondel; Fanny Farrugia; Gwendal Le Masson; Roland Liblau; Daniel Gonzalez-Dunia
Journal:  PLoS Pathog       Date:  2011-11-17       Impact factor: 6.823

4.  Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection.

Authors:  Alex S Hartlage; Satyapramod Murthy; Arvind Kumar; Sheetal Trivedi; Piyush Dravid; Himanshu Sharma; Christopher M Walker; Amit Kapoor
Journal:  Nat Commun       Date:  2019-03-07       Impact factor: 14.919

5.  Monitoring the Dynamics of T Cell Clonal Diversity Using Recombinant Peptide:MHC Technology.

Authors:  J Lori Blanchfield; Shayla K Shorter; Brian D Evavold
Journal:  Front Immunol       Date:  2013-07-03       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.